Abstract:Transfer RNAs (tRNAs) purified from non-pathogenic E. coli strain (NPECS) possess cytotoxic properties on colorectal cancer cells. In the present study, the bioactivity of tRNA halves and tRNA fragments (tRFs) derived from NPECS are investigated for their anticancer potential. Both tRNA halves and tRF mimics studied exhibited significant cytotoxicity on colorectal cancer cells, with the latter being more effective suggesting that tRFs may be important contributors to the bioactivities of tRNAs derived from gut microbiota. Through high-throughput screening, EC83 mimic, a double-strand RNA with a 22 nt 5’-tRF derived from tRNA-Leu(CAA) as antisense chain, was identified as one with the highest potency (IC50=52 nM). Structure-activity investigations revealed that 2’- O -methylation of the ribose of guanosine may enhance the cytotoxic effects of EC83 mimic via increasing the stability of its tertiary structure. Consistently, 4-thiouridine substitution reversed this increased stability and the enhanced cytotoxic effects. This provides the first evidence that the bioactivity of tRF mimics would be impacted by chemical modifications. Furthermore, the present study provides the first evidence to suggest that novel tRNA fragments derived from the gut microbiota may possess anti-cancer properties and have the potential to be potent and selective therapeutic molecules. IMPORTANCE While the gut microbiota has been increasingly recognized to be of vital importance to human health and disease, the current literature shows that there is a lack of attention given on the non-pathogenic Escherichia coli strain. Moreover, the biological activities of tRNA fragments (tRFs) derived from bacteria have rarely been investigated. The findings from this study revealed tRFs as a new class of bioactive constituents derived from gut microorganisms, suggesting that studies on biological functional molecules in intestinal microbiota should not neglect tRFs. The research of tRFs would play an important role in biological research of gut microorganisms, including bacteria-bacteria interaction, gut-brain axis, gut-liver axis, etc. Furthermore, the guidance on the rational design of tRF therapeutics provided in this study indicates that further investigations should pay more attention to these therapeutics from probiotics. The innovative drug research of tRFs as potent druggable RNA molecules derived from intestinal microorganisms would open a new area in biomedical sciences.

Targeting NUCKS1 with a Fragment of Trnaasn(guu) of Chinese Yew for the Treatment of Colorectal Cancer

NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway

A Trna-Derived Fragment from Chinese Yew Suppresses Ovarian Cancer Growth Via Targeting TRPA1

Cross-kingdom regulation of tRNAs/tRFs derived from Chinese yew

A tRF-5a fragment that regulates radiation resistance of colorectal cancer cells by targeting MKNK1

NUCKS1 Promotes Invasion and Metastasis of Colorectal Cancer by Stabilizing HDAC2 and Activating AKT

Notoginsenoside Ft1 inhibits colorectal cancer growth by increasing CD8 + T cell proportion in tumor-bearing mice through the USP9X signaling pathway

Blockade of Nuclear β‐Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis

The Lncrna TUG1 Promotes Cell Growth and Migration in Colorectal Cancer Via the TUG1-miR-145-5p-TRPC6 Pathway

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner

Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1

A Novel Long Non-Coding RNA Lnc-Gnat1-1 is Low Expressed in Colorectal Cancer and Acts As a Tumor Suppressor Through Regulating RKIP-NF-κB-Snail Circuit

Enhanced Chemosensitivity to CPT-11 in Colorectal Carcinoma Xenografts by Small Hairpin RNA Interference Targeting PLK1.

Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy

Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics

Therapeutic Inhibition of SGK1 Suppresses Colorectal Cancer

Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications

Toosendanin-induced Apoptosis in Colorectal Cancer Cells is Associated with the Κ-Opioid Receptor/β-Catenin Signaling Axis.

Cytotoxic Effects of Trna-Derived Fragments and Trna Halves from Non-Pathogenic Escherichia Coli Strain on Colorectal Cancer Cells